French National Registry of Patients With Tetralogy of Fallot and Implantable Cardioverter Defibrillator

Paris Sudden Death Expertise Center150 enrolled

Overview

National french registry of patients with tetralogy of Fallot and implantable cardioverter defibrillator.

Inclusion criteria: * patient with tetralogy of Fallot \> 18 years * implantable cardioverter defibrillator (ICD) * primary or secondary prevention All french centers performing ICD implantation are annually contacted to include all patients with tetralogy of Fallot and ICD. Retrospective inclusion of cases before 2010 and prospective inclusion after 2010 with prospective follow up and annual update. All events are centrally adjudicated with collection of all baseline ECG and reviewing of endocavitary EGM.

Study Type

OBSERVATIONAL

Enrollment

150

Conditions

Tetralogy of Fallot Implantable Defibrillator User Congenital Heart Disease Sudden Cardiac Death Ventricular Arrythmia

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * tetralogy of Fallot * implantable cardioverter defibrillator Exclusion Criteria: * age \< 18 years

Locations (1)

Paris Sudden Death Expertise Center

Paris, France

RECRUITING

Outcomes

Primary Outcomes

Ventricular arrhythmias

Rate of appropriate ICD therapies for ventricular tachycardia and fast ventricular tachycardia / ventricular fibrillation

Time frame: through study completion, an average of 1 year

Complications of ICD

Rate of complications of ICD including inappropriate therapies, infection, lead or generator dysfunction

Time frame: through study completion, an average of 1 year

Central Contacts

Victor Waldmann, MD

CONTACT

+33676098007 vicrtor.waldmann@inserm.fr

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.